Skip to main content
. 2011 Mar 7;17(9):1174–1179. doi: 10.3748/wjg.v17.i9.1174

Figure 2.

Figure 2

Decreasing rate of the modified perianal Crohn’s disease activity index score after surgery in regards to infliximab. The squares represent the median value and the circles represent range plots. The rate of reduction in modified perianal Crohn's disease activity index (mPDAI) score from baseline was significantly greater in patients with infliximab (IFX) -50.0% (0%-90%) - than in those without IFX -28.6% (0%-60%); (P = 0.003).